NYSE:RCUS
Arcus Biosciences Inc. Stock News
$16.90
-0.560 (-3.21%)
At Close: May 17, 2024
Arcus Biosciences Announces New Employment Inducement Grants
04:10pm, Tuesday, 24'th Aug 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensa
Arcus Biosciences, Inc. (RCUS) CEO Terry Rosen on Q2 2021 Results - Earnings Call Transcript
04:37pm, Saturday, 07'th Aug 2021
Arcus Biosciences, Inc. (RCUS) CEO Terry Rosen on Q2 2021 Results - Earnings Call Transcript
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Lags Revenue Estimates
10:03pm, Thursday, 05'th Aug 2021
Arcus Biosciences, Inc. (RCUS) delivered earnings and revenue surprises of -41.56% and -48.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stoc
RCUS Stock Increased 8.03%: Why It Happened
08:04pm, Tuesday, 20'th Jul 2021
The stock price of Arcus Biosciences Inc (NYSE: RCUS) increased by 8.03% today. This is why it happened.
Arcus Biosciences, Inc. (RCUS) Stock Jumps 15.5%: Will It Continue to Soar?
09:46am, Friday, 25'th Jun 2021
Arcus Biosciences, Inc. (RCUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further pr
Why Arcus Biosciences' Big Reveal Wasn't Very Exciting
06:29am, Friday, 25'th Jun 2021
No news from Arcus Biosciences is bad news for the company and other industry heavyweights.
Arcus Biosciences Announces New Employment Inducement Grants
04:10pm, Thursday, 24'th Jun 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensa
Here's Why Arcus Biosciences Stock Is Rising Today
11:54am, Thursday, 24'th Jun 2021
Investors expecting Gilead Sciences to license Arcus Biosciences' lead asset could be in for an unpleasant surprise.
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that, at the firs
Arcus Biosciences Announces New Employment Inducement Grants
04:10pm, Tuesday, 25'th May 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensa
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced initial efficacy
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates
09:25pm, Wednesday, 05'th May 2021
Arcus Biosciences, Inc. (RCUS) delivered earnings and revenue surprises of -52.11% and -49.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the sto
Arcus Biosciences Announces New Employment Inducement Grants
04:10pm, Monday, 26'th Apr 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensa
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today presented progression-free
Arcus Biosciences Announces New Employment Inducement Grants
04:10pm, Friday, 09'th Apr 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensa
